Clinical Trial Update: Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 [NA]

View source ↗

Summary

A completed bosutinib treatment extension study for CML patients who previously participated in related bosutinib trials; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Bosutinib (bosutinib)

Snippet

Sponsor: Pfizer | Conditions: Chronic Myeloid Leukemia | NA | Status: COMPLETED | Results posted: 2021-08-17